glp-1 and prostate cancer GLP1 Receptor Agonists—Effects beyond Obesity Diabetes May Patients Receiving GLP-1 Agonists

SNAC temporarily increases the stomachs pH and makes the stomach wall more permeable, allowing some semaglutide to pass into the bloodstream before digestive enzymes break it down

Energy Expenditure: Semaglutide GLP-1 also activates brown adipose tissue, which burns calories to produce heat, aiding in weight loss through increased energy expenditure

In the landmark 68-week STEP-1 trial, adults with overweight or obesity who reached the 2.4 mg maintenance dose lost roughly 15% of their body weight on average a magnitude that had previously belonged to bariatric surgery, not an injection

The current GLP-1 medications available include semaglutide (brand names Ozempic and Wegovy), tirzepatide (Mounjaro and Zepbound), and liraglutide (Saxenda)